CIK 0002093101 · <br>Emerging growth company
Atrium Therapeutics, Inc.
Sign in to watch- Ticker
- RNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 394639499
- Phone
- 6198760700
- Business address
- 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- 8-K/A Event Other events
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 1 of 3 · 57 filings